Want to see IN:NEULANDLAB full AI Analyst Report?
Neuland Laboratories Ltd. (NEULANDLAB) Ratios
Neuland Laboratories Ltd. Ratios
IN:NEULANDLAB's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:NEULANDLAB's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.09 | 2.45 | 2.15 | 1.73 | 1.60 |
| Quick Ratio | 1.37 | 1.62 | 1.33 | 1.10 | 0.87 |
| Cash Ratio | 0.11 | 0.28 | 0.20 | 0.10 | 0.01 |
| Solvency Ratio | 0.43 | 0.50 | 0.65 | 0.37 | 0.21 |
| Operating Cash Flow Ratio | 0.48 | 0.68 | 0.61 | 0.54 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 9.48 | 7.01 | 6.95 | 5.02 | 0.48 |
| Net Current Asset Value | $ 4.27B | $ 4.84B | $ 3.71B | $ 1.75B | $ 378.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.07 | 0.05 | 0.08 | 0.17 |
| Debt-to-Equity Ratio | 0.16 | 0.10 | 0.07 | 0.13 | 0.29 |
| Debt-to-Capital Ratio | 0.14 | 0.09 | 0.07 | 0.11 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.06 | 0.03 | 0.07 | 0.11 |
| Financial Leverage Ratio | 1.56 | 1.43 | 1.43 | 1.59 | 1.65 |
| Debt Service Coverage Ratio | 8.05 | 6.19 | 7.24 | 3.76 | 0.87 |
| Interest Coverage Ratio | 20.16 | 32.13 | 37.99 | 17.93 | 7.12 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.05 | 0.17 |
| Interest Debt Per Share | 253.48 | 128.94 | 85.26 | 110.30 | 198.00 |
| Net Debt to EBITDA | 0.37 | 0.06 | 0.02 | 0.30 | 1.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.78% | 47.68% | 52.92% | 47.13% | 40.05% |
| EBIT Margin | 25.35% | 24.55% | 26.65% | 19.48% | 9.93% |
| EBITDA Margin | 29.89% | 29.12% | 30.46% | 24.05% | 15.21% |
| Operating Profit Margin | 23.86% | 18.58% | 34.12% | 20.19% | 10.41% |
| Pretax Profit Margin | 24.17% | 24.14% | 25.76% | 18.58% | 8.90% |
| Net Profit Margin | 17.99% | 18.13% | 19.25% | 14.09% | 6.91% |
| Continuous Operations Profit Margin | 17.99% | 18.13% | 19.25% | 14.09% | 6.91% |
| Net Income Per EBT | 74.44% | 75.10% | 74.75% | 75.79% | 77.68% |
| EBT Per EBIT | 101.29% | 129.92% | 75.49% | 92.06% | 85.51% |
| Return on Assets (ROA) | 12.42% | 11.93% | 16.37% | 10.35% | 4.61% |
| Return on Equity (ROE) | 19.42% | 17.06% | 23.39% | 16.45% | 7.59% |
| Return on Capital Employed (ROCE) | 21.75% | 15.55% | 37.85% | 20.54% | 9.42% |
| Return on Invested Capital (ROIC) | 15.90% | 11.36% | 27.49% | 14.91% | 6.49% |
| Return on Tangible Assets | 13.76% | 13.72% | 19.35% | 12.59% | 5.79% |
| Earnings Yield | 2.36% | 1.77% | 3.73% | 7.06% | 4.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.74 | 4.54 | 4.07 | 3.12 | 3.88 |
| Payables Turnover | 5.13 | 2.98 | 3.82 | 3.59 | 4.72 |
| Inventory Turnover | 2.70 | 1.95 | 2.09 | 2.20 | 2.09 |
| Fixed Asset Turnover | 1.84 | 2.00 | 2.64 | 2.33 | 1.90 |
| Asset Turnover | 0.69 | 0.66 | 0.85 | 0.73 | 0.67 |
| Working Capital Turnover Ratio | 2.80 | 2.46 | 3.82 | 4.30 | 4.63 |
| Cash Conversion Cycle | 161.45 | 145.29 | 168.52 | 181.28 | 191.55 |
| Days of Sales Outstanding | 97.67 | 80.34 | 89.70 | 116.92 | 94.07 |
| Days of Inventory Outstanding | 134.97 | 187.61 | 174.30 | 166.05 | 174.89 |
| Days of Payables Outstanding | 71.19 | 122.66 | 95.48 | 101.69 | 77.41 |
| Operating Cycle | 232.64 | 267.95 | 264.01 | 282.97 | 268.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 263.64 | 247.38 | 203.57 | 184.89 | 47.07 |
| Free Cash Flow Per Share | -45.90 | 86.45 | 91.59 | 133.35 | -29.07 |
| Dividend Paid and CapEx Coverage Ratio | 0.82 | 1.41 | 1.67 | 3.27 | 0.59 |
| Capital Expenditure Coverage Ratio | 0.85 | 1.54 | 1.82 | 3.59 | 0.62 |
| Operating Cash Flow Coverage Ratio | 1.12 | 2.02 | 2.74 | 1.85 | 0.25 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.22 | 0.17 | 0.20 | 0.07 |
| Free Cash Flow Yield | -0.38% | 0.75% | 1.46% | 7.39% | -2.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 42.39 | 56.64 | 26.79 | 14.15 | 20.69 |
| Price-to-Sales (P/S) Ratio | 7.63 | 10.27 | 5.16 | 1.99 | 1.43 |
| Price-to-Book (P/B) Ratio | 8.23 | 9.66 | 6.27 | 2.33 | 1.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -262.04 | 132.83 | 68.41 | 13.53 | -35.40 |
| Price-to-Operating Cash Flow Ratio | 45.62 | 46.42 | 30.78 | 9.76 | 21.86 |
| Price-to-Earnings Growth (PEG) Ratio | 1.06 | -4.25 | 0.32 | 0.09 | -0.99 |
| Enterprise Value Multiple | 25.89 | 35.34 | 16.95 | 8.59 | 11.08 |
| Enterprise Value | 156.55B | 147.59B | 80.47B | 23.98B | 15.56B |
| EV to EBITDA | 25.89 | 35.34 | 16.95 | 8.59 | 11.08 |
| EV to Sales | 7.74 | 10.29 | 5.16 | 2.07 | 1.69 |
| EV to Free Cash Flow | -265.85 | 133.06 | 68.48 | 14.01 | -41.71 |
| EV to Operating Cash Flow | 46.28 | 46.50 | 30.81 | 10.11 | 25.76 |
| Tangible Book Value Per Share | 1238.31 | 966.87 | 780.04 | 555.99 | 435.64 |
| Shareholders’ Equity Per Share | 1461.01 | 1188.47 | 999.78 | 774.83 | 655.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.25 | 0.25 | 0.24 | 0.22 |
| Revenue Per Share | 1576.76 | 1117.99 | 1214.80 | 904.84 | 719.67 |
| Net Income Per Share | 283.71 | 202.73 | 233.89 | 127.45 | 49.74 |
| Tax Burden | 0.74 | 0.75 | 0.75 | 0.76 | 0.78 |
| Interest Burden | 0.95 | 0.98 | 0.97 | 0.95 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 |
| SG&A to Revenue | 0.08 | 0.19 | 0.02 | 0.03 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.93 | 0.92 | 0.87 | 1.10 | 0.73 |
Currency in INR